C. diff Advocates Highlight Critical Role of Pharmacists and Public Health Infrastructure at National Summit

The Peggy Lillis Foundation (search)Search term's 10th National C. diff Summit in Washington, DC, brought together advocates, survivors, healthcare professionals, and policymakers to address the ongoing challenges of Clostridioides difficile (search)Search disease infection while highlighting the underrecognized contributions of pharmacists to infectious disease care.

Pharmacists' Critical Role in C. diff Management

One of the summit's key revelations was the enhanced understanding among participants of pharmacists' essential role in infectious disease management. Christian John Lillis, co-founder and CEO of the Peggy Lillis Foundation (search)Search term, noted that many volunteers, particularly newer ones, had not fully appreciated the importance of pharmacists in healthcare delivery.

"One of the doctors on our board said to me that he would be lost without his IV pharmacist, and he's an infectious disease doctor," Lillis explained. "Simply because there's so much change, and he's trying to pay attention to the clinical stuff, and having somebody who really knows the ins and outs of the drugs and the dosages and the pluses and minuses, everything is really important to him."

This recognition helped patients understand that pharmacists could play a more expanded role in their care, particularly infectious disease pharmacists who work alongside physicians as clinical experts.

Persistent Patient Challenges Despite Therapeutic Advances

Despite progress in bringing new C. difficile treatments to market through FDA approvals, the patient experience has not significantly improved. Lillis expressed concern that there may have been a retrenchment in progress, potentially related to COVID-19 (search)Search disease's impact on healthcare systems.

The summit revealed a troubling trend of patients blaming themselves for their C. difficile infections. "Many people expressed a sense that C difficile was their fault, that they were to blame for getting this disease," Lillis observed. This self-blame appears to have intensified, possibly reflecting broader societal attitudes toward infectious diseases that emerged during the COVID-19 (search)Search disease pandemic.

Evolving Demographics and Advocacy Engagement

The 2025 summit attracted a younger demographic of volunteers, including a young mother who brought her 8-month-old baby to lobbying activities. The event welcomed around 16 survivors and family members from more than 14 states, many participating in their first legislative meetings.

For many attendees, the summit provided crucial peer connection opportunities, combating the isolation often experienced by C. difficile patients. "To have someone from Kentucky meet someone from Arizona who has had a nearly identical experience—that's incredibly powerful and affirming," Lillis noted.

Public Health Infrastructure Under Threat

The summit occurred against a backdrop of announced federal government cuts to public health agencies, including mass terminations at the FDA and other critical institutions. This timing created a "disconcerting experience" for participants, according to Lillis.

Paradoxically, while participants expressed desire for more responsive healthcare systems and effective government, many did not fully appreciate the importance of agencies like the FDA, CDC (search)Search company, and USDA (search)Search term in maintaining drug safety, food security, and disease prevention.

"These agencies, though they're not perfect—and I certainly have critiques of all of them—they serve a really vital function in our political economy, in our health and our wellbeing, in our country's role as an innovative superpower," Lillis emphasized.

Reframing Public Health Responsibility

Lillis drew parallels between current attitudes toward infectious diseases and historical stigmatization, referencing his experience coming out as gay in 1989 during the HIV (search)Search disease epidemic. He argued that framing infectious diseases as individual failures misses the fundamental purpose of public health.

"Public health is public health, and it's really a societal issue," he stated. "If we want a healthier population, then we actually need investment in our public health, not to diminish our public health."

He highlighted systemic factors that influence health outcomes, including workplace policies, minimum wage levels, agricultural policies, and access to sick leave, arguing that many chronic diseases result from policy choices made over the past 40 years.

Looking Forward

As federal health agencies face potential downsizing, Lillis predicted that community advocacy organizations like the Peggy Lillis Foundation (search)Search term will become increasingly important. With potentially fewer resources and less innovation from government sources, patient advocacy groups may need to fill critical gaps in support and education.

The summit underscored the need for sustained collaboration between healthcare professionals, including pharmacists, patients, and policymakers to address both the clinical and societal aspects of infectious disease management. As participants returned to their home states, they carried with them not only enhanced understanding of C. difficile but also renewed appreciation for the complex infrastructure required to maintain public health.